Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 45

Sort by

Sort Order Select

Journal Articles

Shiga-like Toxin Producing E. coli Identified in Patients with Multiple Myeloma (MM) Hospitalized Due to Acute Onset Diarrhea; First Report on the Clinical Use of the Biofire Film Array Gastrointestinal Panel

Natalia Kreiniz, Tamar Tadmor, MD, Aaron Polliack, MD, Asala Abu-Ahmad, MD, Orit Golan-Shani, PhD, Paz Alona, MD

Blood (2018) 132 (Supplement 1): 4959.

https://doi.org/10.1182/blood-2018-99-114193

Published: 2018

Journal Articles

Establishment and Evaluation of Gvhd Mouse Model for Allogeneic Hematopoietic Stem Cell Transplantation

Mei Xie, Master, Weihong Chen, MD, Qiaoxia Zhang, PhD, Xin Du, MD

Blood (2018) 132 (Supplement 1): 5681.

https://doi.org/10.1182/blood-2018-99-112486

Published: 2018

Journal Articles

Outcomes of Unrelated Bone Marrow Transplantation in Patients with Thalassemia

Javid Gaziev, Antonella Isgro, MD, Katia Paciaroni, MD, Marco Marziali, MD, Gioia De Angelis, MD, Michela Ribersani, MD, Cecilia Alfieri, MD, Marco Andreani, PhD

Blood (2018) 132 (Supplement 1): 5777.

https://doi.org/10.1182/blood-2018-99-109764

Published: 2018

Journal Articles

Donor Leukocyte Infusion for Single Unit Umbilical Cord Blood Transplantation: 5% of Thawed Single Cord Blood Unit Refrozen on Day of Transplant Is Safe with Signals of Efficacy in Improving Donor Derived Immunity

Mark Vander Lugt, MD, Beth Carella, DO, Heather Stanczak, Xiaohua Chen, MD PhD, Paul Szabolcs, MD

Blood (2018) 132 (Supplement 1): 3414.

https://doi.org/10.1182/blood-2018-99-119261

Published: 2018

Journal Articles

Phase I/II Study of Ruxolitinib for Minimal Residual Disease in Chronic Myeloid Leukemia

Abhishek Maiti, MBBS, Hagop M. Kantarjian, MD, Elias J. Jabbour, MD, Rebecca Poku, MPH, Brittany A Yearby, Stephanie Breakefield, RN, Farhad Ravandi, MD, Jorge E. Cortes, MD

Blood (2018) 132 (Supplement 1): 3009.

https://doi.org/10.1182/blood-2018-99-113972

Published: 2018

Journal Articles

Interim Safety Analysis of a Phase 2 Randomized Study of Daratumumab (Dara), Lenalidomide (R), Bortezomib (V), and Dexamethasone (d; Dara-Rvd) Vs. Rvd in Patients (Pts) with Newly Diagnosed Multiple Myeloma (MM) Eligible for High‐Dose Therapy (HDT) and Autologous Stem Cell Transplantation (ASCT)

Peter M. Voorhees, MD, Luciano J. Costa, MD PhD, Brandi Reeves, MD, Nitya Nathwani, Cesar Rodriguez, MD, Yana Lutska, Laura Hydutsky, Huiling Pei, Jon Ukropec, Ming Qi, Thomas Lin, Paul G Richardson, MD

Blood (2017) 130 (Supplement 1): 1879.

https://doi.org/10.1182/blood.V130.Suppl_1.1879.1879

Published: 2017

Journal Articles

Clinical Outcomes up to 3 Years Following Lentiglobin Gene Therapy for Transfusion-Dependent β-Thalassemia in the Northstar Hgb-204 Study

Janet L. Kwiatkowski, MD, Alexis A Thompson, MD MPH, John Rasko, MBBS, PhD, Suradej Hongeng, MD, Gary J. Schiller, MD, Usanarat Anurathapan, Marina Cavazzana, MD PhD, Phoebe Joy Ho, Christof von Kalle, MD, Morris Kletzel, MD MBA, Philippe Leboulch, MD, Elliott Vichinsky, MD, Briana Deary, Mohammed Asmal, MD PhD, Mark C. Walters, MD

Blood (2017) 130 (Supplement 1): 360.

https://doi.org/10.1182/blood.V130.Suppl_1.360.360

Published: 2017

Journal Articles

A Registry Study on Treatment of Patients with Acquired Protein C Deficiency with a Protein C Concentrate (Human)

Paul Knoebl, MD, Michael Sasse, MD, Maria Pia De Carolis, MD, Jacqueline A Dyck-Jones, PhD, Sandra Ehrle, MD, Maureen Finnerty, David Gelmont, MD, Leman Yel, MD, Mahmoud Loghman-Adham, MD, Doris Fischer, MD

Blood (2016) 128 (22): 3816.

https://doi.org/10.1182/blood.V128.22.3816.3816

Published: 2016

Journal Articles

Pembrolizumab, a PD-1 Inhibitor, in Patients with Myelodysplastic Syndrome (MDS) after Failure of Hypomethylating Agent Treatment

Guillermo Garcia-Manero, MD, Martin S. Tallman, MD, Giovanni Martinelli, MD, Vincent Ribrag, MD, Hui Yang, MD PhD, Arun Balakumaran, MD PhD SM, Sabine Chlosta, MD, Yayan Zhang, PhD, B. Douglas Smith, MD

Blood (2016) 128 (22): 345.

https://doi.org/10.1182/blood.V128.22.345.345

Published: 2016

Journal Articles

Bendamustine-Based (BeEAM) Conditioning before Autologous Stem Cell Transplantation: Result of a French Multicenter Study of 386 Patients from Lysa Centers

Blood (2016) 128 (22): 3450.

https://doi.org/10.1182/blood.V128.22.3450.3450

Published: 2016

Journal Articles

Impact of Previous Invasive Fungal Infections on the Outcome of Patients Undergoing Allogeneic Hematopoietic Stem Cells

Gaetano Maffongelli, Sr., PhD, Gaetano Maffongelli, Sr., PhD, Gaetano Maffongelli, Sr., PhD, Laura Cudillo, MD, Fabio Di Piazza, MSc, Vincenzo Malagnino, Giovanna de Santis, Benedetta Mariotti, Eleonora Ceresoli, Raffaella Cerretti, MD, Alessandra Picardi, MD, Massimo Andreoni, William Arcese, MD, Loredana Sarmati

Blood (2016) 128 (22): 5748.

https://doi.org/10.1182/blood.V128.22.5748.5748

Published: 2016

Journal Articles

Efficacy and Tolerability of the Histone-Deacetylase Inhibitor Panobinostat in Clinical Practice: a Single Center Experience

Marc-A. Baertsch, MD, Jens Hillengass, MD, Stefan Schönland, MD, Ute Hegenbart, MD, Anthony D. Ho, MD, Hartmut Goldschmidt, MD, Marc S. Raab, MD

Blood (2016) 128 (22): 5686.

https://doi.org/10.1182/blood.V128.22.5686.5686

Published: 2016

Journal Articles

Updated Safety and Preliminary Efficacy Data from a Phase 1b Study Combining Venetoclax (GDC-0199, ABT-199) with Bendamustine/Rituximab in Patients with Relapsed/Refractory or Previously Untreated Chronic Lymphocytic Leukemia

Gilles A. Salles, MD PhD, Thomas E. Boyd, MD, Franck Morschhauser, MD, Clemens-Martin Wendtner, MD, Michael Hallek, MD, Barbara F. Eichhorst, MD, Mark Kozloff, MD, Guillaume Cartron, MD PhD, Yan Li, James Hilger, Mehrdad Mobasher, Stephan Stilgenbauer, MD

Blood (2015) 126 (23): 829.

https://doi.org/10.1182/blood.V126.23.829.829

Published: 2015

Journal Articles

Clinical Epidemiology and First-Line Treatment in Immune Thrombocytopenia Adults. Results of the Carmen Prospective Cohort

Blood (2015) 126 (23): 3473.

https://doi.org/10.1182/blood.V126.23.3473.3473

Published: 2015

Journal Articles

Pure Red Cell Aplasia - a New Manifestation of CTLA4 Mutation

Ingunn Dybedal, MDPhD, Anna Mari Lone, PhD, Hanne Sørmo Sorte, MSc, Lorant Farkas, MD PhD, Jürgen Rolke, MD, Robert Brudevold, MD, Asbjørg Stray-Pedersen, MD PhD, Kjetil Tasken, MD PhD

Blood (2015) 126 (23): 2225.

https://doi.org/10.1182/blood.V126.23.2225.2225

Published: 2015

Journal Articles

Safety and Efficacy of Long-Term Open-Label Dosing of Romiplostim in Thrombocytopenic Pediatric Patients (Pts) with Immune Thrombocytopenia (ITP)

James B. Bussel, MD, Michael D. Tarantino, Amy Geddis, Michael F. Guerrera, Alan K. Ikeda, Kun Nie, Janet Franklin, Melissa Eisen

Blood (2014) 124 (21): 4184.

https://doi.org/10.1182/blood.V124.21.4184.4184

Published: 2014

Journal Articles

An Unusual Case of Hypereosinophilic Syndrome

Anwarul Islam, MD

Blood (2014) 124 (21): 4965.

https://doi.org/10.1182/blood.V124.21.4965.4965

Published: 2014

Journal Articles

Incidence, Risk Factors and Outcome Of Cytomegalovirus (CMV) Viremia and CMV Gastroenteritis In Patients With Gastrointestinal Graft Versus Host Disease (GI GVHD)

Divaya Bhutani, MD, Gregory Dyson, MS, Richard Manasa, BS, Voravit Ratanatharathorn, MD, Abhinav Deol, MD, Muneer H. Abidi, MD, Zaid Al-Kadhimi, MD, Lois Ayash, MD, Lawrence G Lum, MD, DSc, Joseph P. Uberti, MD, PhD

Blood (2013) 122 (21): 2039.

https://doi.org/10.1182/blood.V122.21.2039.2039

Published: 2013

Journal Articles

Deferasirox Continues to Reduce Iron Overload in Non-Transfusion-Dependent Thalassemia: A One-Year, Open-Label Extension to a One-Year, Randomized, Double-Blind, Placebo-Controlled Study (THALASSA)

Ali T Taher, MD, John B Porter, MD, Vip Viprakasit, MD, DPhil, Antonis Kattamis, MD, Suporn Chuncharunee, MD, Pranee Sutcharitchan, MD, Noppadol Siritanaratkul, MD, Renzo Galanello, MD, Zeynep Karakas, MD, Tomasz Lawniczek, MD, Dany Habr, MD, Jacqueline Ros, PhD, Zewen Zhu, M Domenica Cappellini, MD

Blood (2012) 120 (21): 3258.

https://doi.org/10.1182/blood.V120.21.3258.3258

Published: 2012

Journal Articles

Patients with Diamond Blackfan Anaemia Have Abnormalities of Cellular and Humoral Immunity

Deena Iskander, MRCP, Yvonne Harrington, RCN, Irene Roberts, Anastasios Karadimitris, MD, PhD, Josu de la Fuente, PhD, FRCP, MRCPCH, FRCPath

Blood (2012) 120 (21): 3484.

https://doi.org/10.1182/blood.V120.21.3484.3484

Published: 2012

NARROW

Shiga-like Toxin Producing E. coli Identified in Patients with Multiple Myeloma (MM) Hospitalized Due to Acute Onset Diarrhea; First Report on the Clinical Use of the Biofire Film Array Gastrointestinal Panel

Establishment and Evaluation of Gvhd Mouse Model for Allogeneic Hematopoietic Stem Cell Transplantation

Outcomes of Unrelated Bone Marrow Transplantation in Patients with Thalassemia

Donor Leukocyte Infusion for Single Unit Umbilical Cord Blood Transplantation: 5% of Thawed Single Cord Blood Unit Refrozen on Day of Transplant Is Safe with Signals of Efficacy in Improving Donor Derived Immunity

Phase I/II Study of Ruxolitinib for Minimal Residual Disease in Chronic Myeloid Leukemia

Interim Safety Analysis of a Phase 2 Randomized Study of Daratumumab (Dara), Lenalidomide (R), Bortezomib (V), and Dexamethasone (d; Dara-Rvd) Vs. Rvd in Patients (Pts) with Newly Diagnosed Multiple Myeloma (MM) Eligible for High‐Dose Therapy (HDT) and Autologous Stem Cell Transplantation (ASCT)

Clinical Outcomes up to 3 Years Following Lentiglobin Gene Therapy for Transfusion-Dependent β-Thalassemia in the Northstar Hgb-204 Study

A Registry Study on Treatment of Patients with Acquired Protein C Deficiency with a Protein C Concentrate (Human)

Pembrolizumab, a PD-1 Inhibitor, in Patients with Myelodysplastic Syndrome (MDS) after Failure of Hypomethylating Agent Treatment

Bendamustine-Based (BeEAM) Conditioning before Autologous Stem Cell Transplantation: Result of a French Multicenter Study of 386 Patients from Lysa Centers

Impact of Previous Invasive Fungal Infections on the Outcome of Patients Undergoing Allogeneic Hematopoietic Stem Cells

Efficacy and Tolerability of the Histone-Deacetylase Inhibitor Panobinostat in Clinical Practice: a Single Center Experience

Updated Safety and Preliminary Efficacy Data from a Phase 1b Study Combining Venetoclax (GDC-0199, ABT-199) with Bendamustine/Rituximab in Patients with Relapsed/Refractory or Previously Untreated Chronic Lymphocytic Leukemia

Clinical Epidemiology and First-Line Treatment in Immune Thrombocytopenia Adults. Results of the Carmen Prospective Cohort

Pure Red Cell Aplasia - a New Manifestation of CTLA4 Mutation

Safety and Efficacy of Long-Term Open-Label Dosing of Romiplostim in Thrombocytopenic Pediatric Patients (Pts) with Immune Thrombocytopenia (ITP)

An Unusual Case of Hypereosinophilic Syndrome

Incidence, Risk Factors and Outcome Of Cytomegalovirus (CMV) Viremia and CMV Gastroenteritis In Patients With Gastrointestinal Graft Versus Host Disease (GI GVHD)

Deferasirox Continues to Reduce Iron Overload in Non-Transfusion-Dependent Thalassemia: A One-Year, Open-Label Extension to a One-Year, Randomized, Double-Blind, Placebo-Controlled Study (THALASSA)

Patients with Diamond Blackfan Anaemia Have Abnormalities of Cellular and Humoral Immunity

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only